On-treatment platelet reactivity through the thromboxane A2 or P2Y12 platelet receptor pathways is not affected by pelacarsen

ConclusionPelacarsen does not modify on-treatment platelet reactivity through the thromboxane A2 or P2Y12 platelet receptor pathways.
Source: Journal of Thrombosis and Thrombolysis - Category: Hematology Source Type: research